NAMPT and metabolic syndrome: Additionally, it was discovered that individuals with MetS had a 129-fold higher frequency (OR = 129.40; 95% CI = 44.576–375.693) of the heterozygous mutant genotype, or GA, for the visfatin SNP rs1215113036 than did the controls.